-

Sapio Sciences Launches Partner Program to Accelerate Research and Diagnostics

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the Sapio Sciences Partner Program. The program provides a growing partner ecosystem of technology vendors, services companies, and resellers with the tools, training, support, and marketing services to deliver solutions that empower scientists.

The Sapio Partner Program ensures services partners are certified in the deployment and support of Sapio's lab informatics platform, helping customers to streamline operations, increase throughput, accelerate discovery, and address compliance requirements in biotech and chemistry research, clinical and molecular diagnostics, pharmaceutical manufacturing, or contract research.

Kevin Cramer, Founder and Chief Executive Officer of Sapio Sciences, said: “The full potential of a genuinely configurable lab informatics platform is realized through the depth and breadth of our partners. Sapio’s open approach allows a huge ecosystem of partners – from lab instrument vendors to specialist ISVs – to configure, deploy, and manage the Sapio platform, and address each client’s precise needs.”

Kevin continued: “For too long, customers have been underserved by the one-sided relationships imposed by lab informatics vendors on their partners. The Sapio Partner Program changes this dynamic, creating a balanced and collaborative environment. By collaborating on our fully configurable platform, scalable data architecture, and unified user experience, Sapio and its partners empower scientists in their truly heroic work.”

The Sapio Partner Program supports three distinct partner ecosystems:

  • Technology: Hardware, Instrument, software, and AI vendors expand the value of the Sapio platform through integration and specialist solution development.
  • Services: Advisory and implementation partners guide customers through the lab automation process and deployment.
  • Reseller: Value-Added Resellers (VARs) and Consultant Resellers resell Sapio’s solutions and add value through additional services such as customization, integration, training, and support.

Training and certification are key elements of the Sapio Partner Program, ensuring joint customers receive the highest possible quality and service from Sapio’s partner ecosystem:

  • Sapio Certified Platform Engineer: Awarded to individuals who demonstrate expertise in designing and implementing Sapio solutions.
  • Sapio Verified Deployment: Awarded to deployment projects that meet or exceed specific Sapio-defined criteria and milestones.
  • Sapio Certified Partner: Awarded to partner companies that meet specific ongoing audited criteria and demonstrate a high level of expertise and competence in Sapio solutions.

Andrew Wyatt, Chief Growth Officer at Sapio Sciences, commented: “The program benefits include access to Sapio experts, training materials, platform roadmaps, and marketing and sales support. We aim to ensure our partners are fully ready to deploy all aspects of Sapio’s highly configurable platform and to professionally support clients in achieving their business goals.”

For more information and joining criteria, visit: https://www.sapiosciences.com/sspp-partner-program-sapio-sciences/

About Sapio Sciences

Sapio Sciences' mission is to improve lives by accelerating discovery, and because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware™ lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions.

Sapio serves some of the largest global and specialist brands, including biopharma, CRO/CDMOs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, chemistry, stability, histopathology, and in vivo studies.

Customers love Sapio's platform because it is robust, scalable, and with no-code configuration, can quickly adapt to meet unique needs.

For more information, visit www.sapiosciences.com and follow us on LinkedIn.

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

Sapio Sciences


Release Versions

Contacts

Zyme Communications
Anna Bakewell
Tel: +44 (0)7801 098 242
Email: anna.bakewell@zymecommunications.com

Tim Brook
Head of PR, Sapio Sciences
Tel: +44 (0)7760 766 213
Email: press@sapiosciences.com

More News From Sapio Sciences

Sapio Sciences Makes AI-Native Drug Discovery Seamless with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio Lab Informatics Platform. This integration brings AI-driven computational drug discovery directly into Sapio ELN (Electronic Lab Notebook), helping to streamline workflows and improve decision-making in drug discovery. With the BioNeMo platform, researchers can accelerate drug discovery by leveraging science-specific AI frameworks...

Sapio Sciences Expands Leadership Team to Drive Growth

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new Scientific Office, Sapio is reinforcing its commitment to scientific and customer-driven innovation. Mike Hampton Joins Sapio to Lead Commercial Strategy and Operations As CCO, Hampton will oversee Sapi...

Sapio Sciences Selected by LabConnect to Transform Laboratory Operations

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced that LabConnect, a global leader in central laboratory services, has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample tracking, and enhance data management. LabConnect partners with biopharma companies and clinical research organizations (CROs) to accelerate the development of new medicines, projects that involv...
Back to Newsroom